Advertisement

Topics

Glythera Limited Company Profile

08:06 EDT 23rd July 2018 | BioPortfolio


News Articles [44 Associated News Articles listed on BioPortfolio]

Glythera appoints Professor Kerry Chester to SAB - Appointment supports the development of the Company’s pipeline

Newcastle, UK, 30th April, 2018: Glythera Limited (Glythera), the next-generation antibody drug conjugate (ADC) development company, today announces that it has appointed Professor Kerry Chester ...

Global leader in ADC characterisation BioOutsource partners with Glythera

BioOutsource Ltd. (“BioOutsource”), a leading international Contract Testing Organization (CTO) has amplified its position as a global leader in Antibody Drug Conjugates (ADC) characterisa...

Glythera makes Significant Appointments to Support Company Expansion

Glythera, a biotechnology company specializing in the development of next generation bio-therapeutics, including Antibody Drug Conjugates,  through the application of its proprietary linker and...

Drug antibody firm collaborates on Innovate UK project

Antibody drug company Glythera has been awarded a grant from the government's innovation agency Innovate UK to develop the next generation of biological therapeutics. Glythera won the £248,000 f...

Glythera appoints Dr Mike Owen as non-executive director

Glythera Limited (‘Glythera’), the next generation antibody drug conjugate (‘ADC’) development company, is pleased to announce the appointment of Dr Mike Owen to the Board as a...

North East Based Biotechnology Firm, Glythera Receives £700k Funding Boost

Glythera Ltd is delighted to announce that it has successfully achieved a number of technical and commercial milestones which has resulted in the release of a second tranche of funding totalling &poun...

Further Shot In Arm For North East With Arrival Of Glythera Following £2M Investment Round

Glythera, an emerging biopharmaceutical company which specialises in increasing the efficacy of biological therapeutics and vaccines, has secured a fundraising round totalling £2m with IP Group,...

Glythera Appoints Professor Kerry Chester to SAB

Appointment supports the development of the Company’s pipeline Glythera Limited (Glythera), the next-generation antibody drug conjugate (ADC) development company, today anno...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [85 Associated Companies listed on BioPortfolio]

Glythera

Glythera Limited

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Glythera Limited" on BioPortfolio

We have published hundreds of Glythera Limited news stories on BioPortfolio along with dozens of Glythera Limited Clinical Trials and PubMed Articles about Glythera Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glythera Limited Companies in our database. You can also find out about relevant Glythera Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record